These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 24569618)

  • 1. Diary of hot flashes reported upon occurrence: results of a randomized double-blind study of raloxifene, placebo, and paroxetine.
    Simon JA; Chandler J; Gottesdiener K; Lazarus N; He W; Rosenberg E; Wagner JA; Denker AE
    Menopause; 2014 Sep; 21(9):938-44. PubMed ID: 24569618
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine controlled release in the treatment of menopausal hot flashes: a randomized controlled trial.
    Stearns V; Beebe KL; Iyengar M; Dube E
    JAMA; 2003 Jun; 289(21):2827-34. PubMed ID: 12783913
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Efficacy of escitalopram for hot flashes in healthy menopausal women: a randomized controlled trial.
    Freeman EW; Guthrie KA; Caan B; Sternfeld B; Cohen LS; Joffe H; Carpenter JS; Anderson GL; Larson JC; Ensrud KE; Reed SD; Newton KM; Sherman S; Sammel MD; LaCroix AZ
    JAMA; 2011 Jan; 305(3):267-74. PubMed ID: 21245182
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of paroxetine in the management of hot flashes in gynecological cancer survivors: Results of the first randomized single-center controlled trial.
    Capriglione S; Plotti F; Montera R; Luvero D; Lopez S; Scaletta G; Aloisi A; Serra GB; Angioli R
    Gynecol Oncol; 2016 Dec; 143(3):584-588. PubMed ID: 27751589
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Characterization of hot flashes reported by healthy postmenopausal women receiving raloxifene or placebo during osteoporosis prevention trials.
    Cohen FJ; Lu Y
    Maturitas; 2000 Jan; 34(1):65-73. PubMed ID: 10687884
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Low-dose paroxetine 7.5 mg for menopausal vasomotor symptoms: two randomized controlled trials.
    Simon JA; Portman DJ; Kaunitz AM; Mekonnen H; Kazempour K; Bhaskar S; Lippman J
    Menopause; 2013 Oct; 20(10):1027-35. PubMed ID: 24045678
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical investigation of RAD1901, a novel estrogen receptor ligand, for the treatment of postmenopausal vasomotor symptoms: a phase 2 randomized, placebo-controlled, double-blind, dose-ranging, proof-of-concept trial.
    Hattersley G; Harris AG; Simon JA; Constantine GD
    Menopause; 2017 Jan; 24(1):92-99. PubMed ID: 27575546
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A pilot trial assessing the efficacy of paroxetine hydrochloride (Paxil) in controlling hot flashes in breast cancer survivors.
    Stearns V; Isaacs C; Rowland J; Crawford J; Ellis MJ; Kramer R; Lawrence W; Hanfelt JJ; Hayes DF
    Ann Oncol; 2000 Jan; 11(1):17-22. PubMed ID: 10690382
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy of Continuous Transdermal Nitroglycerin for Treating Hot Flashes by Inducing Nitrate Cross-tolerance in Perimenopausal and Postmenopausal Women: A Randomized Clinical Trial.
    Huang AJ; Cummings SR; Ganz P; Schembri M; Raghunathan H; Vittinghoff E; Gibson CJ; Grady D
    JAMA Intern Med; 2023 Aug; 183(8):776-783. PubMed ID: 37273224
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Paroxetine is an effective treatment for hot flashes: results from a prospective randomized clinical trial.
    Stearns V; Slack R; Greep N; Henry-Tilman R; Osborne M; Bunnell C; Ullmer L; Gallagher A; Cullen J; Gehan E; Hayes DF; Isaacs C
    J Clin Oncol; 2005 Oct; 23(28):6919-30. PubMed ID: 16192581
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of low-dose paroxetine 7.5 mg on weight and sexual function during treatment of vasomotor symptoms associated with menopause.
    Portman DJ; Kaunitz AM; Kazempour K; Mekonnen H; Bhaskar S; Lippman J
    Menopause; 2014 Oct; 21(10):1082-90. PubMed ID: 24552977
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Transition from estrogen therapy to raloxifene in postmenopausal women: effects on treatment satisfaction and the endometrium-a pilot study.
    Davis SR; O'Neill SM; Eden J; Baber R; Ekangaki A; Stocks JM; Thiebaud D
    Menopause; 2004; 11(2):167-75. PubMed ID: 15021446
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Low-dose paroxetine (7.5 mg) improves sleep in women with vasomotor symptoms associated with menopause.
    Pinkerton JV; Joffe H; Kazempour K; Mekonnen H; Bhaskar S; Lippman J
    Menopause; 2015 Jan; 22(1):50-8. PubMed ID: 25137243
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transition from estrogen-progestin to raloxifene in postmenopausal women: effect on vasomotor symptoms.
    Gordon S; Walsh BW; Ciaccia AV; Siddhanti S; Rosen AS; Plouffe L
    Obstet Gynecol; 2004 Feb; 103(2):267-73. PubMed ID: 14754694
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The variable response of women with menopausal hot flashes when treated with sertraline.
    Kerwin JP; Gordon PR; Senf JH
    Menopause; 2007; 14(5):841-5. PubMed ID: 17413648
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Randomized, double-blind, placebo-controlled, crossover study of sertraline (Zoloft) for the treatment of hot flashes in women with early stage breast cancer taking tamoxifen.
    Kimmick GG; Lovato J; McQuellon R; Robinson E; Muss HB
    Breast J; 2006; 12(2):114-22. PubMed ID: 16509835
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Effect of escitalopram on hot flash interference: a randomized, controlled trial.
    Carpenter JS; Guthrie KA; Larson JC; Freeman EW; Joffe H; Reed SD; Ensrud KE; LaCroix AZ
    Fertil Steril; 2012 Jun; 97(6):1399-404.e1. PubMed ID: 22480818
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Efficacy of Low-Dose Paroxetine for the Treatment of Hot Flushes in Surgical and Physiological Postmenopausal Women: Systematic Review and Meta-Analysis of Randomized Trials.
    Riemma G; Schiattarella A; La Verde M; Zarobbi G; Garzon S; Cucinella G; Calagna G; Labriola D; De Franciscis P
    Medicina (Kaunas); 2019 Aug; 55(9):. PubMed ID: 31480427
    [No Abstract]   [Full Text] [Related]  

  • 19. The effect of varying low-dose combinations of norethindrone acetate and ethinyl estradiol (femhrt) on the frequency and intensity of vasomotor symptoms.
    Speroff L; Symons J; Kempfert N; Rowan J;
    Menopause; 2000; 7(6):383-90. PubMed ID: 11127760
    [TBL] [Abstract][Full Text] [Related]  

  • 20. North Central Cancer Treatment Group N10C2 (Alliance): a double-blind placebo-controlled study of magnesium supplements to reduce menopausal hot flashes.
    Park H; Qin R; Smith TJ; Atherton PJ; Barton DL; Sturtz K; Dakhil SR; Anderson DM; Flynn K; Puttabasavaiah S; Le-Lindqwister NA; Padula GD; Loprinzi CL
    Menopause; 2015 Jun; 22(6):627-32. PubMed ID: 25423327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.